Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Apoptin-induced apoptosis: a review.

M H Noteborn1

  • 1Leadd BV and Department of Molecular Cell Biology, Leiden University Medical Center, Wassenaarseweg 72, 2300 RA Leiden, The Netherlands. noteborn@leadd.nl

Apoptosis : an International Journal on Programmed Cell Death
|November 25, 2003
PubMed
Summary

Apoptin, a viral protein, selectively triggers cancer cell death (apoptosis) independently of p53. This protein shows promise as a safe and effective anti-tumor therapy, particularly in animal models.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Apoptin-induced apoptosis: potential for antitumor therapy.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2006
Same author

Potentiation of a recombinant oncolytic parvovirus by expression of Apoptin.

Cancer gene therapy·2002
Same author

Response to apoptin of diploid fibroblasts from cancer-prone syndromes.

Developments in biologicals·2002
Same author

Studies on the pathogenesis of chicken infectious anaemia virus infection in six-week-old SPF chickens.

Acta veterinaria Hungarica·2001
Same author

The chicken anemia virus-derived protein apoptin requires activation of caspases for induction of apoptosis in human tumor cells.

Journal of virology·2000
Same author

BCL-2 stimulates Apoptin-induced apoptosis.

Advances in experimental medicine and biology·1999

Area of Science:

  • Oncology
  • Molecular Biology
  • Virology

Background:

  • Apoptin is a protein derived from an avian virus with demonstrated ability to induce apoptosis.
  • Apoptosis is a critical cellular process for eliminating damaged or unwanted cells, and its dysregulation is a hallmark of cancer.
  • The proto-oncogene Bcl-2 typically inhibits apoptosis, but its interaction with Apoptin presents a unique scenario.

Purpose of the Study:

  • To investigate the mechanism of Apoptin-induced apoptosis in various human tumor cell lines.
  • To determine the role of p53 and Bcl-2 in Apoptin's apoptotic activity.
  • To evaluate the therapeutic potential of Apoptin as an anti-cancer agent in preclinical models.

Main Methods:

  • Culturing various human tumorigenic and transformed cell lines (breast, lung, leukemia, lymphoma, osteosarcoma, melanoma, cholangiocarcinoma, hepatoma).
  • Treating cell lines with Apoptin and assessing apoptosis induction.
  • Over-expressing Bcl-2 in normal and tumor cells to study its effect on Apoptin activity.
  • Evaluating Apoptin's efficacy and safety in animal models.

Main Results:

  • Apoptin induced p53-independent apoptosis in diverse human tumor cell lines.
  • The proto-oncogene Bcl-2 accelerated Apoptin-induced apoptosis in tumor cells, contrary to its general inhibitory role.
  • Apoptin did not induce apoptosis in normal human cells, even with Bcl-2 over-expression.
  • Apoptin demonstrated safe and efficient anti-tumor activity in animal models.

Conclusions:

  • Apoptin selectively targets tumor cells for apoptosis, sparing normal cells.
  • The p53-independent and Bcl-2-accelerated apoptotic pathway makes Apoptin a unique anti-cancer therapeutic candidate.
  • Apoptin represents a promising novel anti-tumor therapy with a favorable safety profile.

Related Experiment Videos